The Aristotle Classes on PH & ACHD is a scientific event organised jointly by the Medical School of Aristotle University, Thessaloniki, Greece, the Heart Center at the University of Cologne, Germany and Royal Brompton & Harefield Hospitals, Imperial College, London, UK.

Congratulations to Joseph Newman, who was presented with the ELF Travel grant 10 September at the ERS Congress in Vienna for the best abstract in patient centred research entitled 'The Pulmonary Hypertension Global Patient Survey (PH GPS): an overview and results'. 

The submission deadline for submitting PVRI 2025 Rio abstracts has been extended! The best abstracts will be considered for travel awards. All accepted abstracts will be published in our journal, Pulmonary Circulation, and may appear on our website. 

The PVRI Innovative Drug Development Initiative (IDDI) Access to Care Workstream created the Access to Care poster which was presented at the PHA Conference in Indianapolis (15-18 August, 2024).

The purpose of the the Pulmonary Hypertension Association’s award is to support research aimed at addressing early diagnosis, education, and improving clinical outcomes and treatments for pulmonary hypertension (PH) patients who may be impacted by health inequities. Awards may be approved for up to a two (2) year period, up to $50,000/year.

Applications for the Pulmonary Hypertension/Pulmonary Vascular Disease (PH/PVD) Fellowship at the University of Pennsylvania for the academic year starting July 2025 are open.

Cereno Scientific, a pioneering biotech developing innovative treatments for rare and common cardiovascular diseases, has joined PVRI as a Roundtable member.

The Burke Advanced Fellowship in Pulmonary Heart Disease at The Brigham and Women’s Hospital and Harvard Medical School invites applications for an advanced fellowship in pulmonary heart disease starting 1 July 2025.